RICTOR and non-small cell lung carcinoma: For example, the genomic profiles of NSCLC patients have been shown to differ in those with brain metastases compared to those without, with enrichment in alterations such as KRAS, NFKBIA, and RICTOR among patients with CNS involvement [19,118].